3B Blackbio DX Ltd (3BBLACKBIO) — FY26 Annual Report | 7 September 2026 (2 announcements)

3B Blackbio DX Ltd reported FY 2025-26 revenue of ₹14,191.81 crores with [amount not verified]thousand net profit and [amount context mismatch] EPS, while proposing a 50% dividend** and expanding its TRUPCR® portfolio to 70+ countries post-Coris BioConcept acquisition. The filing confirms unqualified auditor opinion, compliance with SEBI and accounting standards, and governance details including board fees and committee structures.

The company announced that shareholders who have not registered their email addresses will receive a notice directing them to access the Annual Report 2025-26 via the company website and BSE portal. The 54th AGM is scheduled for September 29, 2026 at 11:30 AM IST via video conference, with e-voting open from September 26 to 28, 2026. Shareholders are urged to update KYC details and register emails to receive future communications.